Clinical Trials in Massachusetts

Showing 9781-9800 of 13,570 trials

Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Non-Hodgkin's Lymphoma

NCT00110149

RATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growth in different ways. Some block the ability of cancer cells to grow and spread. Others, such as yttrium Y 90 ibritumomab tiuxetan, find cancer cells and help kill them or carry cancer-killing substances to them without harming normal cells. Giving rituximab together with yttrium Y 90 ibritumomab tiuxetan may kill more cancer cells. PURPOSE: This phase II trial is studying how well giving rituximab together with yttrium Y 90 ibritumomab tiuxetan works in treating patients with indolent non-Hodgkin's lymphoma.

Lymphoma

Beth Israel Deaconess Medical Center12 participantsStarted May 2004

Boston, Massachusetts, United States • Lebanon, New Hampshire, United States • Burlington, Vermont, United States

COMPLETEDPhase 326 miles

Study of Dupilumab Monotherapy Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis

NCT02277743

This is a randomized, double-blind, placebo-controlled, parallel group study to confirm the efficacy and safety of Dupilumab monotherapy in adults with moderate-to-severe atopic dermatitis (AD).

Dermatitis, Atopic

Regeneron Pharmaceuticals671 participantsStarted Oct 2014

Birmingham, Alabama, United States • Fort Smith, Arkansas, United States • Rogers, Arkansas, United States +98 more locations

Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Non-Hodgkin's Lymphoma

Study of Dupilumab Monotherapy Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis

Find Trials by Condition in Massachusetts

A Study of ABT-806 in Subjects With Advanced Solid Tumor Types

A Study of Vemurafenib in Participants With BRAF V600 Mutation-Positive Cancers

Significance of Antibodies to Heparin/Platelet Factor 4 Complex in Vein Graft Patency and Potential Role of Argatroban for Prevention of Vein Graft Occlusion

Ninvasive Cardiac Output Measurements During Cesarean Delivery Under Spinal Anesthesia.

Vaccination of Patients With Breast Cancer With Dendritic Cell/Tumor Fusions and IL-12

Randomized, Placebo Controlled Study Of The Efficacy And Safety Of PF-02545920 In Subjects With Huntington's Disease

Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Cancer of the Vulva

Safety and Efficacy of BRM421 for Dry Eye Syndrome

Intravenous BI 6727 (Volasertib) in 2nd Line Treatment of Urothelial Cancer

A Study to Assess the Effect of Ketoconazole on the Metabolism of ABT-199

Randomized Switch Study From Hydroxyurea to Ruxolitinib for RELIEF of Polycythemia Vera Symptoms: The Relief Study

A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of ABT-199 in Female Patients With Systemic Lupus Erythematosus (SLE)

Proof of Concept (POC) in Patients With Ischaemic Stroke

Safety Escalating Repeat IV, in Stroke Patients

A Phase I Study Of Pazopanib With Either Erlotinib Or Pemetrexed In Patients With Advanced Solid Tumors

Natural Evolution of AV Conduction Disorders in Patients Implanted With Cardiac Pacemakers

Immunogenicity and Safety Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals H7N1 Influenza Vaccine Administered to Adults 65 Years of Age and Older

Study To Examine The Effects Of Lapatinib On The Pharmacokinetics Of Digoxin In Subjects w/ ErbB2 Positive Breast Cancer